Ultragenyx (RARE) delivered earnings and revenue surprises of -12.10% and 1.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Moderna (MRNA) delivered earnings and revenue surprises of 7.06% and 1.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Arcutis Biotherapeutics (ARQT) was a big mover last session on higher-than-average trading volume. The latest trend in ...

Leuven.IRD (Institute for Rare Diseases), LIGAS (Institute for Genetics and Society) and LIVO (Educational Research Institute). These institutes carry out interdisciplinary research with a societal ...

Robert F. Kennedy, Jr., has expressed support for some fields of science but has also declared he’d like a “break” in ...

Kennedy has expressed support for some fields, but has also declared he’d like a ‘break’ in infectious-disease research.

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

The Michigan AG's Office sued over a policy change that cuts reimbursements to universities for overhead costs related to ...

A $30,000 scholarship programme will be launched alongside internship opportunities for science graduates as Roche Bermuda ...